DALBAVANCIN/BIOARS
FORM
Powder for concentrate for solution for infusion
STRENGTH
500 mg
INDICATIONS
Dalbavancin is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults and paediatric patients aged 3 months and older
Important note
Dalbavancin must be reconstituted with sterile water for injections and subsequently diluted with 50 mg/ml (5 %) glucose solution for infusion.
Dalbavancin vials are for single-use only.
